Kids Beating Cancer is now accepting Letters of Intent for the 2025 cycle of the John Voight Memorial Leukemia Research Grant, a competitive two-tiered program totaling up to 300,000 USD over three years. This award is dedicated to accelerating the development of innovative treatments for pediatric leukemia, with a strong focus on Acute Myelocytic Leukemia (AML).
Who is eligible?
Applicants must:
-
Be based at a U.S. nonprofit or academic research institution
-
Hold an MD, PhD, or MD/PhD (or equivalent) and a faculty (or equivalent) position
-
Have a proven track record in pediatric cancer research
-
Submit original, unpublished work (conference abstracts must show significant updates)
-
Ensure no budgetary or scientific overlap with other active grants
-
Postdoctoral researchers are eligible to apply
Funding at a glance:
-
Tier 1: 100,000 USD for 1 year to demonstrate feasibility and gather pilot data
-
Tier 2: 200,000 USD for 2 years (invitation-only, contingent on Tier 1 results)
-
Funds may cover PI salary (within NIH cap), personnel, equipment, and supplies
-
Indirect costs, administrative expenses, travel, and PR costs are not allowed
Research focus:
The grant supports translational leukemia research aimed at therapeutic development, biomarker discovery, or any innovative intervention with the potential to impact pediatric AML patients within several years.
Key deadlines:
-
Letter of Intent Due: July 1, 2025
-
Invitation to Apply Notification: August 1, 2025
-
Full Proposal Deadline: September 15, 2025
-
Award Notification: November–December 2025
Where to apply:
All submissions must be made via ProposalCentral. Format and instructions must follow NIH-style standards.
Questions?
Contact:
-
Sam Azar (COO & VP of Research) – [email protected]
-
Ian Henrich, PhD (Chair, Scientific Advisory Board) – [email protected]